Maria Grazia Vitale

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma

P. Grover, Serigne Lo, Isabel Li, Anke Kuijpers et autres

au, nl, us, gb, de, ch, pl, it, fr, se, il, be, at, es (code pays fourni par la source)

Acral lentiginous melanoma shows a poorer response to immune checkpoint inhibition in the non-resectable or metastatic setting – A EUMelaReg real world outcome study

M. Weichenthal, Anne Zaremba, Nethanel Asher, J. Mangana et autres

de, il, ch, bg, es, rs, hr, ba, it, gr, pl (code pays fourni par la source)

69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors

E. Speziale, Leonardo Brunetti, Valentina Santo, Marco Tucci et autres

it, gb (code pays fourni par la source)

Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma

Paolo A. Ascierto, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni et autres

it, pl, es, gr, at, fr, in, se, ch (code pays fourni par la source)

Efficacy of adjuvant therapy in patients (pts) with AJCC v8 stage IIIA cutaneous melanoma.

Piyush Grover, Isabel Li, Anke Kuijpers, Firas Kreidieh et autres

au, nl, us, gb, de, ch, pl, it, fr, se, il (code pays fourni par la source)

Author response for "High seroprevalence of Leishmania infantum infection in dogs and its associated risk factors in selected towns of Southwest and West Shewa zones of Oromia, Ethiopia"

Endrias Zewdu Gebremedhin, Weraka Weya, Chala Dima, Demeke Zewde et autres

308 Transcriptomic analysis of melanoma patients in adjuvant setting treated with anti PD1 therapy: real life study

Domenico Mallardo, Claudia Trojaniello, Maria Grazia Vitale, Grazia D’Angelo et autres

it, us (code pays fourni par la source)

934 Biological mechanisms in the different etiologies of Merkel cell carcinoma patients: polyomavirus or UV exposure

Domenico Mallardo, Giosuè Scognamiglio, Khrystyna North, Mariaelena Capone et autres

it, us (code pays fourni par la source)

1049P Clinical models to predict response in mucosal melanoma (MM) patients (pts) treated with anti-PD-1 (PD1) or combined with ipilimumab (PD1+IPI)

Florentia Dimitriou, Kenjiro Namikawa, Paweł Teterycz, Irene L. M. Reijers et autres

au, pl, nl, us, de, it, cn, fr, sg (code pays fourni par la source)

BRAF Gene and Melanoma: Back to the Future

Margaret Ottaviano, Emilio Francesco Giunta, Marianna Tortora, Marcello Curvietto et autres

it (code pays fourni par la source)

Management of immune-related adverse events: A single-center retrospective analysis in a real-world scenario.

Donatella Iacono, Maria Grazia Vitale, Francesco Cortiula, Marianna Macerelli et autres

it (code pays fourni par la source)

Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario

Donatella Iacono, Maria Grazia Vitale, Francesco Cortiula, M. Cinausero et autres

it (code pays fourni par la source)